GW Resident Segment – January 2018 Edition with Dr. Hsu
In this throwback edition of the JDD Podcast "Ask the Investigator," host Adam Friedman speaks with Dr. Sylvia Hsu, Professor and Chair of Dermatology at the Lewis Katz School of Medicine at Temple University on her study published in the August 2008 edition of the JDD entitled, "A Case Series of 48 Patients Treated with Thalidomide." Get a taste of rich dermatology history with the evolution of t …
Continue reading "GW Resident Segment – January 2018 Edition with Dr. Hsu"
Question 1
In your JDD podcast interview, you mentioned that about 50-60% of your patients with LPP respond to naltrexone. Have you seen any similarities between these responders that could help dermatologists identify which patients would be good candidates for naltrexone as an adjunctive therapy?
Answer
"No I have not seen any similarities. The response is unpredictable."
Quest … 
Human fibroblasts are a versatile source of optimal growth factors that provide approaches to repair skin in Upregulation of Extracellular Matrix Genes Corroborates Clinical Efficacy of Human Fibroblast-Derived Growth Factors in Skin Rejuvenation
By working from a CD8+ T cell line, it should be possible to identify and patent products capable of treating infectious diseases, antigen- … 
Catch up on your JDD reading with highlights from the August issue, Special Focus: Psoriasis.
Strober, Bagel, and Lebwohl et al present Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study READ NOW
The Static Physician’s Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Ps … 